Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Lefer

Showing results (111-120 of 489) with videos related to

Pageof 49
Sort By:
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1974
Properties of the reticuloendothelial system of the catR J Gorczynski, A M Lefer
Basic Research in Cardiology|January 1, 1991
Endothelial dysfunction in myocardial ischemia and reperfusion: role of oxygen-derived free radicalsA M Lefer, D J Lefer
Advances in Shock Research|January 1, 1978
Amelioration of splanchnic artery occlusion (SAO) shock by cysteineM J Galvin, A M Lefer
Progress in Clinical and Biological Research|January 1, 1985
Leukotrienes in coronary angiopathy of diabetesD M Roth, A M Lefer
Thrombosis Research|May 1, 1976
Influence of humoral shock factors on in vitro aggregation of dog plateletsG A Bridenbaugh, A M Lefer
Pharmacological Research|January 1, 1991
Endothelial alterations in hypercholesterolaemia and atherosclerosisA M Lefer, A W Sedar
Research Communications in Chemical Pathology and Pharmacology|November 1, 1990
Cardioprotective actions of the specific thromboxane receptor antagonist (+)-S145Na following coronary occlusion and reperfusion in the ratP S Tsao, A M Lefer
American Heart Journal|April 1, 1981
Stabilization of cardiac lysosomal and cellular membranes in protection of ischemic myocardium due to coronary occlusion:efficacy of the nonsteroidal anti-inflammatory agent, naproxenE F Smith, A M Lefer
Life Sciences|September 28, 1981
Salutary actions of nimodipine in traumatic shockA M Lefer, B A Carrow
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1985
Thromboxanes as mediators of cardiovascular disease statesA M Lefer, J B Smith
Pageof 49

Showing results (111-120 of 489) with videos related to

Sort By:
Pageof 49
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1974
Properties of the reticuloendothelial system of the catR J Gorczynski, A M Lefer
Basic Research in Cardiology|January 1, 1991
Endothelial dysfunction in myocardial ischemia and reperfusion: role of oxygen-derived free radicalsA M Lefer, D J Lefer
Advances in Shock Research|January 1, 1978
Amelioration of splanchnic artery occlusion (SAO) shock by cysteineM J Galvin, A M Lefer
Progress in Clinical and Biological Research|January 1, 1985
Leukotrienes in coronary angiopathy of diabetesD M Roth, A M Lefer
Thrombosis Research|May 1, 1976
Influence of humoral shock factors on in vitro aggregation of dog plateletsG A Bridenbaugh, A M Lefer
Pharmacological Research|January 1, 1991
Endothelial alterations in hypercholesterolaemia and atherosclerosisA M Lefer, A W Sedar
Research Communications in Chemical Pathology and Pharmacology|November 1, 1990
Cardioprotective actions of the specific thromboxane receptor antagonist (+)-S145Na following coronary occlusion and reperfusion in the ratP S Tsao, A M Lefer
American Heart Journal|April 1, 1981
Stabilization of cardiac lysosomal and cellular membranes in protection of ischemic myocardium due to coronary occlusion:efficacy of the nonsteroidal anti-inflammatory agent, naproxenE F Smith, A M Lefer
Life Sciences|September 28, 1981
Salutary actions of nimodipine in traumatic shockA M Lefer, B A Carrow
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1985
Thromboxanes as mediators of cardiovascular disease statesA M Lefer, J B Smith
Pageof 49